APA (7th ed.) Citation

C, N., MA, S., A, D., A, P., & J, N. (2017). Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region. Medical oncology (Northwood, London, England), 34(9), 149. https://doi.org/10.1007/s12032-017-1002-6

Chicago Style (17th ed.) Citation

C, Nieder, Syed MA, Dalhaug A, Pawinski A, and Norum J. "Eligibility for Phase 3 Clinical Trials of Systemic Therapy in Real-world Patients with Metastatic Renal Cell Cancer Managed in a Rural Region." Medical Oncology (Northwood, London, England) 34, no. 9 (2017): 149. https://doi.org/10.1007/s12032-017-1002-6.

MLA (9th ed.) Citation

C, Nieder, et al. "Eligibility for Phase 3 Clinical Trials of Systemic Therapy in Real-world Patients with Metastatic Renal Cell Cancer Managed in a Rural Region." Medical Oncology (Northwood, London, England), vol. 34, no. 9, 2017, p. 149, https://doi.org/10.1007/s12032-017-1002-6.